UNA NUEVA ALTERNATIVA EN EL MANEJO DE LA ÚLCERA VASCULAR COMPLEJA CON FACTOR DE CRECIMIENTO EPIDERMICO RECOMBINANTE, EPIPROT® (NEPIDERMINA)
Texto completo
Documento similar
(2015) Human Epidermal Growth Factor Receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the Immunotherapy of HER2- positive sarcoma.. Journal of
Makino, “Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep
This study analyzes whether the release of nitric oxide (NO) and thromboxane A 2 (TXA 2 ) depends on the time lapsed since gonadal function is lost, and their correlation with
Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: results of a phase I
Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D 3 is mediated by mutual modulation of receptor expression. The down-regulation
Nguyen PL, Swanson PE, Jaszcz W, et al (1994) Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: a multivariate
Serum levels of vascular endothelial growth factor-A 165 , soluble vascular endothelial growth factor receptor 1, and hepatocyte growth factor were assessed by
Representative vascular endothelial growth factor A (VEGF-A) immunostaining of placenta sections (A) and Western blot VEGF-A protein analysis in placental lysed samples (B) for